Physician profile
Katie E Steele
NPI 1023302254
$3,278.63
in general payments reported to CMS, 2019-2025
35 companies · $675 in 2025
The $675 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $121 · 2021: $466 · 2022: $773 · 2023: $474 · 2024: $439 · 2025: $675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.14 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $542.84 | 2019-2025 | Orilissa, Lo Loestrin Fe, Ubrelvy |
| Mayne Pharma Commercial LLC | $415.17 | 2021-2025 | |
| Astellas Pharma US INC | $380.45 | 2019-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $219.18 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $210.14 | 2023-2025 | Myfembree |
| Agile Therapeutics, INC. | $146.17 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $130.24 | 2019-2022 | |
| Exeltis, USA INC. | $126.81 | 2019-2025 | Slynd |
| Exact Sciences Corporation | $100.85 | 2023-2025 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $99.67 | 2022-2024 | Ova1 |
| Daiichi Sankyo INC. | $95.36 | 2019-2022 | |
| Evofem Biosciences, INC. | $94.53 | 2021-2022 | |
| Coopersurgical, INC. | $84.41 | 2020-2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $76.16 | 2019-2025 | |
| Shield Therapeutics INC | $61.70 | 2023-2025 | Accrufer |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.48 | 2019-2023 | |
| Organon LLC | $54.99 | 2022-2025 | Nexplanon, Jada System |
| Lupin INC. | $49.86 | 2019-2021 | |
| Minerva Surgical, INC | $40.71 | 2021-2022 | |
| Hologic Sales and Service, LLC | $38.55 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Myosure Tissue Removal Device, Omni Hysteroscope |
| Takeda Pharmaceuticals U.S.A., INC. | $37.55 | 2019 | |
| Alexion Pharmaceuticals, INC. | $28.36 | 2019-2025 | Ultomiris |
| Myovant Sciences INC. | $20.88 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.32 | 2022 | |
| Roche Diagnostics Corporation | $17.50 | 2019 | |
| Millicent US INC | $17.22 | 2025 | Intrarosa |
| Alydia Health | $16.25 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.05 | 2019 | |
| Medtronic, INC. | $15.74 | 2023 | Ligasure |
| Duchesnay USA Incorporated | $14.88 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.66 | 2020 | |
| Avanos Medical | $13.50 | 2021 | |
| Alfasigma USA, INC. | $11.56 | 2020 | |
| Allergan, INC. | $10.89 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Steele listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.